Compounding Pharmacy · Livonia, MI · 503A

Vios Compounding Review

Vios Compounding (legal entity SNF Holdings, LLC dba Vios Compounding) is a 503A compounding pharmacy in Livonia, Michigan that compounds semaglutide and tirzepatide (GLP-1), including injectable vials (1 mg or 5 mg strength in 1 mL or 2.5 mL) and GLP-1 oral strips/transmucosal films, prepared per individual prescription. The FDA issued a state referral letter to the pharmacy in April 2024. Note: routine 503A compounding of GLP-1s that copy commercially available products is restricted now that the FDA shortages are resolved.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503A
Location: Livonia, MI
States licensed: 0
4.5
★★☆☆☆2.3/5

Editorial score · methodology

Top-Rated GLP-1 Partners

Not sourced from Vios Compounding — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

7.8

Care Bare Rx

LGBTQ+-inclusive compounded GLP-1 telehealth

Starting price: $199/mo

Get started →Read review Care Bare Rx →
8.2

Enhance MD

Lab-monitored compounded GLP-1 with mandatory video visit

Starting price: $112/mo

Get started →Read review Enhance MD →
7.1

MEDVi

Switching between compounded and brand-name GLP-1 through one provider

Starting price: $179/mo

Get started →Read review MEDVi →
7.3

Liv Body

Compounded GLP-1 paired with a muscle-preservation supplement stack

Starting price: $99/mo

Get started →Read review Liv Body →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

We have not verified any third-party accreditations for this pharmacy beyond its state pharmacy license.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

Vios Compounding has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

Regulatory Actions

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing5/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Last verified 2026-06-04 via manual · How we verify provider data

Frequently Asked Questions

Vios Compounding is a 503A compounding pharmacy based in Livonia, MI. It operates under state board of pharmacy licensure. Note: our records show 1 documented regulatory action(s) — see the Regulatory Actions section below.
Vios Compounding is headquartered in Livonia, MI. The pharmacy is licensed to ship to 0 US states.
Vios Compounding produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of September 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.